Effect of methylphenidate on sleep parameters in children with ADHD

Psychiatry Investigation

Volumn 9, Issue 4, 2012, Pages 384-390

  Lee, Sang Heon ^a   Seox, Wan Seok ^a   Sung, Hyung Mo ^b   Choi, Tae Young ^c   Kim, So Yeun ^a   Choi, So Jeong ^a   Koo, Bon Hoon ^a   Lee, Jong Hun ^c  

^a Yeungnam University College of Medicine   (South Korea)

^b CHA University   (South Korea)

^c Catholic University of Daegu   (South Korea)

Author keywords

ADHD; Children; Metadate CD; Methylphenidate; OROS MPH

Indexed keywords

METHYLPHENIDATE;

ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; CLINICAL GLOBAL IMPRESSION SCALE; CONTROLLED STUDY; DRUG MEGADOSE; DRUG WITHDRAWAL; FEMALE; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MORNING DOSAGE; PHASE 4 CLINICAL TRIAL; PRESCHOOL CHILD; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RECOMMENDED DRUG DOSE; SCHOOL CHILD; SLEEP PARAMETERS; SLEEP TIME; UNSPECIFIED SIDE EFFECT; WECHSLER INTELLIGENCE SCALE;

EID: 84871537266     PISSN: 17383684     EISSN: 19763026     Source Type: Journal    
DOI: 10.4306/pi.2012.9.4.384     Document Type: Article

References (26)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-IV TR. Washington DC: American Psychiatric Association; 2000.
2. Concannon PE, Tang YP. Management of attention deficit hyperactivity disorder: a parental perspective. J Paediatr Child Health 2005;41:625-630.
3. Capp PK, Pearl PL, Conlon C. Methylphenidate HCl: therapy for attention deficit hyperactivity disorder. Expert Rev Neurother 2005;5:325-331.
4. Dulcan M. Practice parameters for the assessment and treatment of children, adolescents, and adults with attention-deficit/hyperactivity disorder. American Academy of Child and Adolescent Psychiatry. J Am Acad Child Adolesc Psychiatry 1997;36(10 Suppl):85S-121S.
5. Kratochvil CJ, Lake M, Pliszka SR, Walkup JT. Pharmacological management of treatment-induced insomnia in ADHD. J Am Acad Child Adolesc Psychiatry 2005;44:499-501.
6. Martins S, Tramontina S, Polanczyk G, Eizirik M, Swanson JM, Rohde LA. Weekend holidays during methylphenidate use in ADHD children: a randomized clinical trial. J Child Adolesc Psychopharmacol 2004; 14:195-206.
7. Rapport MD, Randall R, Moffitt C. Attention-Deficit/Hyperactivity Disorder and methylphenidate: a dose-response analysis and parent-child comparison of somatic complaints. J Atten Disord 2002;6:15-24.
8. Sangal RB, Owens J, Allen AJ, Sutton V, Schuh K, Kelsey D. Effects of atomoxetine and methylphenidate on sleep in children with ADHD. Sleep 2006;29:1573-1585.
9. Stein MA. Unravelling sleep problems in treated and untreated children with ADHD. J Child Adolesc Psychopharmacol 1999;9:157-168.
10. Galland BC, Tripp EG, Taylor BJ. The sleep of children with attention deficit hyperactivity disorder on and off methylphenidate: a matched case-control study. J Sleep Res 2010;19:366-373.
11. Ashkenasi A. Effect of transdermal methylphenidate wear times on sleep in children with attention deficit hyperactivity disorder. Pediatr Neurol 2011;45:381-386.
12. Kim HW, Yoon IY, Cho SC, Kim BN, Chung S, Lee H, et al. The effect of OROS methylphenidate on the sleep of children with attention-deficit/hyperactivity disorder. Int Clin Psychopharmacol 2010;25:107-115.
13. Anstead M. Pediatric sleep disorders: new developments and evolving understanding. Curr Opin Pulm Med 2000;6:501-506.
14. Fallone G, Acebo C, Arnedt JT, Seifer R, Carskadon MA. Effects of acute sleep restriction on behavior, sustained attention, and response inhibition in children. Percept Mot Skills 2001;93:213-229.
15. Stenuit P, Kerkhofs M. Effects of sleep restriction on cognition in women. Biol Psychol 2008;77:81-88.
16. van der Heijden KB, Smits MG, Gunning WB. Sleep-related disorders in ADHD: a review. Clin Pediatr (Phila) 2005;44:201-210.
17. Kaufman J, Birmaher B, Brent D, Rao U, Flynn C, Moreci P, et al. Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry 1997;36:980-988.
18. Kim YS, Cheon KA, Kim BN, Chang SA, Yoo HJ, Kim JW, et al. The reliability and validity of Kiddie-Schedule for Affective Disorders and Schizophrenia-Present and Lifetime Version- Korean version (K-SADSPL- K). Yonsei Med J 2004;45:81-89.
19. Ng DK, Kwok KL, Cheung JM, Leung SY, Chow PY, Wong WH, et al. Prevalence of sleep problems in Hong Kong primary school children: a community-based telephone survey. Chest 2005;128:1315-1323.
20. Seo WS, Sung HM, Lee JH, Koo BH, Kim MJ, Kim SY, et al. Sleep patterns and their age-related changes in elementary-school children. Sleep Med 2010;11:569-575.
21. Corkum P, Panton R, Ironside S, Macpherson M, Williams T. Acute impact of immediate release methylphenidate administered three times a day on sleep in children with attention-deficit/hyperactivity disorder. J Pediatr Psychol 2008;33:368-379.
22. Schwartz G, Amor LB, Grizenko N, Lageix P, Baron C, Boivin DB, et al. Actigraphic monitoring during sleep of children with ADHD on methylphenidate and placebo. J Am Acad Child Adolesc Psychiatry 2004; 43:1276-1282.
23. Faraone SV, Glatt SJ, Bukstein OG, Lopez FA, Arnold LE, Findling RL. Effects of once-daily oral and transdermal methylphenidate on sleep behavior of children with ADHD. J Atten Disord 2009;12:308-315.
24. Rochdi M, Gonzalez MA, Dirksen SJ. Dose-proportional pharmacokinetics of a methylphenidate extended-release capsule. Int J Clin Pharmacol Ther 2004;42:285-292.
25. Modi NB, Lindemulder B, Gupta SK. Single- and multiple-dose pharmacokinetics of an oral once-a-day osmotic controlled-release OROS (methylphenidate HCl) formulation. J Clin Pharmacol 2000;40:379-388.
26. Pelham WE, Gnagy EM, Burrows-Maclean L, Williams A, Fabiano GA, Morrisey SM, et al. Once-a-day Concerta methylphenidate versus threetimes-daily methylphenidate in laboratory and natural settings. Pediatrics 2001;107:E105.